Table. 2.

Patient demographic data and operative outcomes (compared between the ambulatory group and a group of patients with ASA III)

Ambulatory (n = 51) ASA III (n = 28) p-value
Age (yr) 43.66 ± 11.36 68.60 ± 14.70 < 0.001
Male 10 (19.61) 15 (53.50) 0.019
BMI (kg/m2) 25.28 ± 3.60 25.61 ± 5.70 0.75
Diagnosis
Symptomatic gallstone 43 (84.31) 10 (35.71) < 0.001
Chronic cholecystitis 3 (5.88) 10 (3.57) 0.001
Bile duct stone after stone removal 5 (9.80) 6 (21.43) 0.18
Gallbladder polyp 0 (0) 1 (3.57) 0.35
Gallstone pancreatitis 0 (0) 1 (0.35) 0.35
Underlying disease
DM 4 (7.84) 15 (53.57) < 0.001
HT 8 (15.69) 25 (89.29) < 0.001
Ischemic heart disease 0 (0) 5 (17.86) 0.004
Operative time (min) 40.33 ± 17.24 55.96 ± 26.45 0.002
Conversion 0 (0) 2 (7.14) 0.12
EBL (mL) 8.11 ± 9.91 47.82 ± 134.91 0.03
Readmission 1 (1.96) 1 (3.57) > 0.999
Complication
Wound infection 2 (3.92) 1 (3.57) > 0.999
Bile duct injury 0 (0) 1 (3.57) 0.35

Values are presented as mean ± standard deviation or number (%).

ASA, American Society of Anesthesiologists; BMI, body mass index; DM, diabetes mellitus; HT, hypertension; EBL, estimated blood loss.

Ann Hepatobiliary Pancreat Surg 2024;28:381-7 https://doi.org/10.14701/ahbps.24-056
© 2024 Ann Hepatobiliary Pancreat Surg